Lipocine Inc.
Bioavailable solid state (17-.beta.)-hydroxy-4-androsten-3-one esters
Last updated:
Abstract:
Disclosed are bioavailable solid state (17-.beta.)-Hydroxy-4-Androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-.beta.)-Hydroxy-4-Androsten-3-one.
Status:
Grant
Type:
Utility
Filling date:
15 Apr 2020
Issue date:
12 Apr 2022